Is Green Thumb Industries Inc (GTBIF) overvalued? · P/E 31, rev $311.1M
Green Thumb Industries Inc (GTBIF) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Green Thumb Industries Inc (GTBIF) looks expensive on cached numbers — not a short thesis.
Latest reported GTBIF revenue for 2025-12-31 was $311.1M. Net income was $83.2M. Revenue was up 6.8% from 2025-09-30 to 2025-12-31. GTBIF currently screens at market cap $1.57B and trailing P/E 31.2.
GTBIF currently screens at market cap $1.57B and trailing P/E 31.2. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GTBIF 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GTBIF stock page for the full model, not this heading.
Not investment advice.